Researchers Weigh In on Evidence About Cancer Treatment Side Effects in Africa

A brief but pointed exchange in the journal Supportive Care in Cancer has drawn attention to how scientific evidence about cancer treatment side effects in Africa is generated, reviewed, and contested. The latest instalment is a response letter published on 14 September 2026 by Matthew J. Allsop of the University of Leeds and Kamaldeen Abdulraheem of Lagos University Teaching Hospital, written in reply to a comment by Veldi VDK, R. Mehta, and R. Sah. The exchange sits atop a larger piece of work: a systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients, led by O. Salako and colleagues and published in the same journal in April 2025.

Correspondence sections of medical journals rarely make headlines, yet they perform a function that is essential to the credibility of research. When a systematic review is published, other researchers scrutinise its methods, its interpretation of the data, and the conclusions drawn from it. Comments and response letters are the formal record of that scrutiny. In this case, the chain runs in three links: the original meta-analysis by Salako and colleagues, a comment on that analysis by Veldi and co-authors published on 25 April 2025, and now the response from Allsop and Abdulraheem, which was received on 6 May 2026, accepted on 10 September 2026, and published four days later as article number 968 in volume 34 of the journal.

The underlying subject matter is of substantial clinical importance. Systematic reviews and meta-analyses are considered among the strongest forms of evidence in medicine because they pool results from multiple primary studies, increasing statistical power and revealing patterns that individual trials may miss. When the focus is on side effects of non-surgical cancer treatments, such as chemotherapy and radiotherapy, in a specific population, the review can inform how clinicians anticipate toxicities, how health systems allocate supportive care resources, and how policymakers prioritise services. For African cancer patients, whose treatment contexts often differ in drug access, diagnostic capacity, and supportive care infrastructure from those in high-income countries, region-specific syntheses of evidence are particularly valuable.

The original meta-analysis by Salako, Habeebu, Okediji and colleagues appeared in Supportive Care in Cancer in 2025 under the title A systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients. The journal, published by Springer Nature, specialises in the supportive and palliative dimensions of cancer care, spanning symptom management, treatment toxicities, psychosocial support, and quality of life. A meta-analysis in this space typically aggregates reported rates of adverse effects across cohorts and trials from multiple countries, then estimates pooled incidences and explores sources of heterogeneity between studies. Such work requires careful handling of variation in how side effects are graded, recorded, and reported across different settings.

That methodological challenge is precisely where commentaries tend to focus. Heterogeneity, meaning genuine or statistical variation between the studies being pooled, is a central concern in any meta-analysis. If included studies differ in patient populations, tumour types, treatment regimens, toxicity grading systems, or follow-up durations, the pooled estimates may obscure more than they reveal. Reviewers of such work commonly probe the search strategy, the inclusion criteria, the risk-of-bias assessment, and whether the authors’ conclusions respect the limitations of the underlying data. Comments published in response to a meta-analysis frequently raise exactly these points, and the authors’ reply is an opportunity to defend, clarify, or concede ground.

The comment by Veldi, Mehta and Sah, published as article 415 in volume 33 of the journal, entered that debate in April 2025. The full text of the comment and of the new response letter are available to subscribers of the journal, and the publicly available record establishes the structure of the exchange without disclosing the detailed arguments within it. What can be stated with confidence is that Allsop and Abdulraheem felt the comment warranted a formal reply, and that the journal’s editors accepted the response for publication after peer review of the correspondence, a process reflected in the received and accepted dates recorded for the letter.

The authorship of the response is notable for the collaboration it represents. Matthew J. Allsop is based in the Academic Unit of Palliative Care at the Leeds Institute of Health Sciences, University of Leeds, in the United Kingdom, a group with a research profile in palliative and supportive cancer care. Kamaldeen Abdulraheem is based in the Department of Community Health at Lagos University Teaching Hospital in Nigeria, one of the country’s major tertiary medical institutions. A joint reply from a UK palliative care researcher and a Nigerian community health specialist mirrors the kind of international partnership that global oncology advocates argue is needed to produce research that is both locally grounded and internationally visible. According to the contributions statement, Allsop wrote the first draft of the manuscript and Abdulraheem commented on it, with both authors reading and approving the final version.

The administrative record of the letter also illustrates the norms that govern this kind of publication. The authors declare that no funds, grants, or other support were received during its preparation, and that they have no competing interests. Because the response letter relied exclusively on secondary published data, the authors state that no ethical approval was required, a standard position for correspondence that analyses no new patient-level information. The letter carries a CrossMark record, the publisher’s mechanism for signalling the version of record and any updates, and its citation is fixed by the DOI 10.1007/s00520-026-11221-9, which identifies the response itself and must not be confused with the DOIs of the original article or the comment it addresses.

For readers outside the specialty, the significance of such an exchange lies in what it says about the self-correcting machinery of science. A meta-analysis makes claims on behalf of a whole body of literature; a comment tests those claims; a response defends or refines them. Each step is documented, dated, and citable, allowing future researchers to trace how consensus formed or fractured. In fields such as supportive care in cancer, where clinical guidance increasingly draws on pooled evidence, the visibility of these debates matters. Clinicians who read only the headline findings of a meta-analysis may miss the caveats raised in correspondence, which is why journals archive comments and responses alongside the primary article and link them through shared DOIs and reference lists.

The exchange also underscores the growing research attention to cancer care in Africa, where rising incidence, limited access to treatment, and constrained supportive care services make reliable evidence on treatment toxicities a pressing need. Reviews conducted by African-led teams, such as the Salako and colleagues meta-analysis, and the international scholarly dialogue that follows them, contribute to building an evidence base that reflects the realities of care in the region rather than extrapolating from data generated elsewhere. Whether the points raised by Veldi and co-authors lead to revisions in how such reviews are conducted, or to new analyses with expanded data, remains to be seen. What the published record shows is that the conversation is active, that researchers in Leeds and Lagos consider the questions important enough to answer formally, and that the journal has provided a permanent, citable home for that answer in volume 34 of Supportive Care in Cancer.

Subject of Research: Scholarly correspondence on a meta-analysis of side effects of non-surgical cancer treatments in African cancer patients

Article Title: Response comment to Veldi et al.

Article References: Allsop, M. J., & Abdulraheem, K. (2026). Response comment to Veldi et al.. Supportive Care in Cancer, 34(10), Article 968. https://doi.org/10.1007/s00520-026-11221-9

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11221-9

Keywords: supportive care in cancer, meta-analysis, systematic review, African cancer patients, treatment side effects, non-surgical treatments, oncology, research correspondence, global health, palliative care, cancer toxicities, evidence synthesis